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The interaction of a new group of ‘quinomycin-like’ antibiotics with the DNA duplexes d(ACGT& and d(GACGTCh has been investigated in 
solution by ‘H NMR spectroscopy. By monitoring the intensity of intranucleotide base H6/H8 to deoxyribose Hl’NOE cross-peaks we conclude 
that the terminal A-T basepairs flanking the CG bisintercalation site in the d(ACGT), complex adopt the Hoogsteen bonding scheme, with the 
purine base in a syn conformation. By comparison in the d(GACGTC), complex all glycosidic bond angles are anti, consistent with a preferred 
Watson-Crick basepairing scheme. Both DNA duplexes appear to be significantly unwound compared with the &and-free DNAs. The data illus- 
trate the influence of helical constraints on the stability of the Hoogsteen bonding scheme adjacent o the drug binding sites. 
Quinomycin antibiotic; d(ACGTX; d(GACGTC)2; ‘H NMR NOESY; Watson-Crick/Hoogsteen basepair 
1. INTRODUCTION 
The quinoxaline antitumour antibiotics are a family 
of cyclic depsipeptides whose biological properties 
result from their ability to bind to DNA in susceptible 
cells and interfere with nucleic acid synthesis [ 1,2]. 
Echinomycin, the best known of this class of com- 
pounds, binds to DNA through the process of bisinter- 
calation [3] and the structure of its DNA complex has 
been elucidated by X-ray crystallographic analysis 
[4]. A remarkable feature of the (echinomycin)z- 
d(CGTACG)z complex, in which drug molecules 
bracket the terminal CG basepairs, is that the an- 
tibiotics induce Hoogsteen basepairing in the two cen- 
tral A-T basepairs of the complex. In this conformation 
the purine bases are flipped into a syn orientation about 
the glycosidic bond and a different hydrogen bonding 
scheme is adopted between the two components of the 
basepair (see Fig. 1). Several studies have been directed 
towards determining the existence, or otherwise, of 
such a radical drug-induced structural change in solu- 
tion. The hyper-reactivity of DNA to diethylpyrocar- 
bonate (DEPC) in the presence of echinomycin has 
been interpreted by Mendel and Dervan [5] in terms of 
an altered DNA conformation involving Hoogsteen 
basepairing, while recent results have led McLean and 
Waring [6] to propose that the DEPC reactivity be in- 
terpreted in terms of sequence-specific unwinding of the 
DNA helix. To date, two solution NMR studies have 
been brought to bare on this issue. Gao and Pate1 [7] 
have revealed that the terminal A-T basepairs of an 
echinomycin complex with d(ACGT)z, but not with 
d(TCGA)z, are Hoogsteen basepaired in solution, il- 
lustrating the sequence dependent nature of the 
phenomenon. Gilbert et al. [8] also report that the 
terminal A-T basepairs of an (echinomycin)z- 
d(ACGTACGT)z complex are stably Hoogsteen paired 
while the A-T basepairs at the core of the duplex are 
unstable but adopt the Hoogsteen pairing scheme at low 
temperatures where the structure is similar to that 
found in the echinomycin-DNA crystal structure [4]. 
Recently, we have investigated the interaction of a 
new family of ‘quinomycin-like’ antibiotics [9] (see Fig. 
2) with several defined-sequence oligonucleotide 
duplexes using NMR spectroscopy. These compounds 
have several novel structural features, such as 
3-hydroxy-quinaldic acid chromophores replacing the 
quinoxaline rings of echinomycin, and methyl- 
cyclopropyl groups replacing the valine residues, which 
are capable of modifying their DNA binding 
characteristics compared with echinomycin. Of im- 
mediate interest is the effect of these antibiotics on the 
A-T basepairing scheme flanking the 5 ’ -CG binding 
sites in the duplexes d(ACGT)z and d(GACGTC)z. 
2. MATERIALS AND METHODS 
Correspondence address: M.S. Searle, Peter MacCallum Cancer In- 
stitute NMR Facility, Victorian College of Pharmacy, 381 Royal 
Parade, Parkville, Victoria 3052, Australia 
A sample of UK-65,662 (factor B) was kindly provided by Pfizer 
Ltd. (Sandwich, Kent, UK) and was used without further purifica- 
tion. Samples were prepared by dissolving two equivalents of drug in 
0.5 ml of acetonitrile to which was added 0.5 ml of aqueous buffer (10 
mM phosphate, 50 mM NaCl, pH 7.0) containing the appropriate 
oligonucleotide. The mixture was diluted to 5 ml with DzO and the 
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a sample of d(GACGTC)z in which 70-80% of the duplex was ligand 
bound. 
‘H NMR spectra were collected at 400 MHz on a Varian VXR400 
wide-bore spectrometer. Phase-sensitive NOESY experiments were 
performed using the hypercomplex method of data collection. The 
data were recorded as 1024 points in tz for each of 2 x 320-360 tl 
values, over a spectral width of 4000 Hz, and zero-filled to a 
2048 x 2048 data matrix prior to Fourier transformation using mild 
squared-guassian window functions. Data acquisition times of 24 h 
were typically employed. 
’ Ht’ Watson-Crick 
’ HI’ 
Hoogsteen 
Fig. 1. A schematic representation of A-T basepairs in both the 
Watson-Crick and Hoogsteen pairing schemes. Arrows identify the 
interproton distances (H8-Hl ’) used to monitor the glycosidic bond 
conformation. 
solution stirred for 48 h in a cold-room at 4°C. The solution was then 
lyophilized and redissolved in 0.5 ml of DzO with the excess drug be- 
ing removed by centrifugation. The QN/d(ACGT)z complex formed 
readily under these conditions while NMR studies were undertaken on 
October 1990 
3. RESULTS AND DISCUSSION 
The glycosidic bond angles in a Watson-Crick 
basepaired B-DNA helical structure lie in the anti range 
[lo] and this conformation is associated with a par- 
ticularly weak intranucleotide NOE between base 
H6/H8 and the deoxyribose Hl’ corresponding to a 
proton-proton separation of 3.5-3.7 A. In the Hoog- 
Steen basepairing scheme (see Fig. 1) the purine base is 
flipped into a syn orientation about the glycosidic bond 
in which the base H8 to deoxyribose Hl’ distance 
decreases dramatically to 2.5-2.7 A. The intensity of 
this NOE, calibrated with respect to a fixed reference 
distance such as that between the cytosine base H5 and 
H6 (2.5 A), provides a convenient means of 
discriminating between the Watson-Crick and Hoog- 
Steen basepairing schemes. The effects of UK-65,662 
(QN) on the basepairing schemes in its complexes with 
d(ACGT)z and d(GACGTC)z have been i vestigated by 
monitoring the intensity of these cross-peaks in 100 ms 
NOESY spectra at 20°C. In both complexes a large 
number of intermolecular NOES clearly identifies the 
depsipeptide ring of the antibiotic as binding in the 
CHS 
0 \7 
Fig. 2. Structure of UK-65,662 (factor B). 
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C6 - Gl 
QN-d(GACGTC), 
Fig. 3. Schematic representation of the QN/d(ACGTh and 
QN/d(GACGTC)z complexes including the nucleotide numbering 
scheme adopted. 
QN-d(ACGT), 
oG3 
minor groove bracketing the CG basepairs at the centre 
of each duplex as illustrated schematically in Fig. 3. A 
detailed description of resonance assignments and the 
structure and dynamics of these complexes will be 
published elsewhere. 
In Fig. 4 both stack plot and contour plot representa- 
tions of the H6/H8-Hl’ region of the NOESY spec- 
trum of QN/d(ACGT)z are illustrated. Intranucleotide 
H6/H8-Hl ’ cross-peaks are labelled on the contour 
plot while the stack plot presentation provides a clearer 
comparison between cross-peak intensities relative to 
the cytosine reference peak (labelled C2). It is apparent 
that a much stronger NOE is observed for AlH8-Hl’ 
than for any of the remaining base H6/H8 and sugar 
Hl’ interactions. The comparable intensity of the Al 
cross-peak to that of C2 H5-H6 demonstrates that Al 
adopts a syn glycosidic orientation, consistent with the 
Hoogsteen basepairing scheme for Al-T4, while those 
of C2-G3 are Watson-Crick basepaired. Thus the an- 
QN-d(GACGTC), , 
A2 
7.5 _ T5iC6 
0 
- 
Gl 
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Fig. 4. Stack plot and contour plot represenations of the 100 ms NOESY spectra of QN/d(ACGT)z and QN/d(GACGTC)z recorded at 20°C. The 
portions of the spectra containing the H6/H8-HI ’ inter- and intranucleotide NOE cross-peaks are highlighted. Intranucleotide connectivities are 
labelled together with the cytosine HS-H6 reference peaks (underlined) in each spectrum. The antibiotic molecule lacks a two-fold symmetry axis 
and partially removes the two-fold symmetry of the two duplexes under study. This is only clearly visible for the A2H8 resonances in the 
QN/d(GACGTC)z complex, in all other cases the chemical shift differences are too small to resolve in the NOESY spectra. 
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tibiotic UK-65,662 induces similar conformational 
changes in d(ACGT)2 to those reported for 
echinomycin by Gao and Pate1 [7]. 
A similar region of the 100 ms NOESY spectrum of 
the QN/d(GACGTC)z complex is also illustrated in 
Fig. 4. Again the intranucleotide H6/H8-HI’ cross- 
peaks are labelled and all are found to have very low in- 
tensities compared with the C3 and C6 reference peaks, 
including those for A2 (equivalent o Al in the tetramer 
complex; see Fig. 3). We conclude that in the complex 
with d(GACGTC)z, under the same experimental con- 
ditions, all glycosidic bonds are in the anti conforma- 
tion indicative of basepairs adopting the Watson-Crick 
pairing scheme. It is also apparent hat in the spectra of 
both complexes internucleotide H6/H8-Hl ’ correla- 
tions, also found in the portions of the NOESY spectra 
illustrated in Fig. 4, are particularly weak compared 
with intranucleotide interactions. This observation, 
together with the pronounced downfield shifts in the 
31P NMR spectra of these duplexes (data not shown), 
leads us to conclude that there is a high degree of un- 
winding of the DNA helix associated with ligand bin- 
ding. 
The data indicate that quite different influences are 
at work in stabilizing the A-T basepairing scheme 
within these two complexes. In the absence of helical 
constraints, as is the case in the QN/d(ACGT)z com- 
plex, the A-T basepairs adopt the Hoogsteen pairing 
scheme. This suggests that the most favourable stacking 
interactions are those involving the quinoline 
chromophores and the six-membered ring of the purine 
base when flipped into the syn conformation, as 
reported for the crystalline complex of echinomycin [4]. 
In the longer sequence of DNA, the A-T basepairs 
flanking the CG binding site are subject to the helical 
constraints imposed by the terminal G-C basepairs and 
in this situation the Hoogsteen pairing scheme is not 
preferred. These results together with those of Gilbert 
et al. [8] illustrate the inherent instability of the Hoog- 
Steen basepairing scheme in solution within the con- 
straints of an extended B-DNA helix. 
In conclusion, our structural interpretation of the 
data reported here on the QN/d(GACGTC)z complex 
parallels that of McLean and Waring for the observed 
DEPC hyper-reactivity of natural DNA in the presence 
of quinomycin antibiotics [a]. Their model favours 
sequence-specific unwinding of the DNA helix as the 
source of the enhanced reactivity, rather than structural 
changes involving Hoogsteen basepairing. Recent 
evidence from Fox and Kentebe [ 1 l] suggests that struc- 
tural changes induced by echinomycin are not confined 
to regions surrounding the drug binding sites but can be 
cooperatively propagated over several turns of the 
DNA helix. The structural basis for these phenomena 
will be more clearly understood when further solution 
NMR data become available on DNA complexes of 
these antibiotics. 
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